The VOICE-COVID study will evaluate the concordance of screening for symptoms of COVID-19 using a voice based device (Amazon Alexa) compared to manual screening by a study coordinator for individuals entering the Cardiology/Heart Failure clinic at the McGill University Health Centre.
This study is an open-label, prospective, cross-over randomized study.
VOICE-COVID I: All individuals entering the Heart Failure (HF) Clinic of the McGill
University Health Center will be asked to participate. A poster with instructions to ask the
participants (employees or patients) to speak with the Amazon Alexa device. The participant
will remain 6 feet away from the device. The Amazon Alexa will ask the survey questions. A
study coordinator will then ask the same questions along with some additional questions about
Amazon Alexa usability. VOICE-COVID II: A second cohort of 52 people will be then randomized
to be screened for symptoms of COVID-19 with an Amazon Alexa or a coordinator. We will study
the correlation between the Alexa response and the response to the study coordinator using
K-squared statistic tests and screening question concordance.
Device: Alexa Amazon
To test the use of the Amazon Alexa device as a tool to conduct screening of employees and patients at the point of entry into the Heart Failure (HF) Clinic of the McGill University Health Center.
Inclusion Criteria:
- Adults >=18 yrs who is entering the HF clinic
- Speaks either English or French
Exclusion Criteria:
- None
Muhc-Rimuhc
Montreal, Quebec, Canada
Investigator: Abhinav h Sharma, MD
Contact: 514 934-1934
abhinav.sharma@mcgill.ca
Investigator: Abhinav Sharma, MD
Abhinav Sharma, MD
514 934-1934
abhinav.sharma@mcgill.ca
Alexandria Flannery, RN
514 934-1934 - 35414
dreamcvlab@muhc.mcgill.ca
Abhinav Sharma, MD, Principal Investigator
McGill University Health Centre/Research Institute of the McGill University Health Centre